Ara
Toplam kayıt 157, listelenen: 151-157
Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey
(S. Karger AG, 2014)
Introduction: In Turkey, the gene expression profile test is not standard, so adjuvant treatment is planned according to clinicopathological factors. Therefore, we retrospectively analyzed important parameters that affect ...
Our experience in chordee without hypospadias: Results of 102 cases
(Urology and Nephrology Research Centre, 2014)
Purpose: We present long-term surgical experience of 102 chordee without hypospadias cases. Materials and Methods: This retrospective study included 102 chordee without hypospadias cases who were surgically treated between ...
Pea3 transcription factor promotes neurite outgrowth
(Frontiers Research Foundation, 2014)
Pea3 subfamily of E-twenty six transcription factors consist of three major -exhibit branching morphogenesis, the function of Pea3 family in nervous system development and regeneration is only beginning to unfold. In this ...
Primate vaginal microbiomes exhibit species specificity without universal Lactobacillus dominance
(Nature Publishing Group, 2014)
Bacterial communities colonizing the reproductive tracts of primates (including humans) impact the health, survival and fitness of the host, and thereby the evolution of the host species. Despite their importance, we ...
Identification of ApoA1, HPX and POTEE genes by omic analysis in breast cancer
(Spandidos Publications, 2014)
Breast cancer is the most common cancer among women and accounts for 23% of all female types of cancers. It is well recognized that breast cancer represents a heterogeneous group of tumors, and the molecular events involved ...
Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions
(Baishideng Publishing Group Inc, 2014)
AIM: To investigate whether amifostine contributes to the antioxidant and cytoprotective effects of histidine-tryptophan-ketoglutarate (HTK) and University of Wisconsin (UW) preservation solutions. METHODS: Forty-eight ...
What is the optimal treatment in clinical stage T3N0M0 rectal cancer?
(Zerbinis Medical Publications, 2014)
Purpose: Some previous studies suggested that certain rectal cancer patients with stage T3N0 and favorable features may be adequately treated with surgery and adjuvant chemotherapy. However, the optimal management of ...